Resultados: 113

    Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV

    These recommendations have been developed specifically to address the daily use of antiretrovirals in HIV-uninfected people to block the acquisition of HIV infection. This prevention approach is known as pre-exposure prophylaxis. At this stage evidence is available from studies with two groups: men and t...

    Guidance on prevention of viral hepatitis B and C among people who inject drugs

    The guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization. The following recommendations are based on systematic reviews of scientific evidence, community values and preferences and implementation i...

    Guidance on couples HIV testing and counselling: including antiretroviral therapy for treatment and prevention in serodiscordant couples

    This WHO guidelines recommend offering HIV testing and counselling to couples, wherever HIV testing and counselling is available, including in antenatal clinics. For couples where only one partner is HIV positive, the guidelines recommend offering antiretroviral therapy to the HIV positive partner, regar...

    Blood donor selection: guidelines on assessing donor suitability for blood donation

    These WHO guidelines, Blood donor selection: guidelines on assessing donor suitability for blood donation have been developed to assist blood transfusion services in countries that are establishing or strengthening national systems for the selection of blood donors. They are designed for use by policy ma...

    Collaborative framework for care and control of tuberculosis and diabetes

    Intersecting epidemics Tuberculosis (TB) remains a considerable global public health concern, mainly affecting poor and vulnerable populations. Every year, more than 9 million people fall ill with this infectious disease, and close to 2 million die from it. Diabetes, a chronic metabolic disease that is i...

    Guidelines:prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people: recommendations for a public health approach 2011

    Since the beginning of the epidemic in the early 1980s, men who have sex with men (MSM) and transgender people have been disproportionately affected by the human immunodeficiency virus (HIV). The risk for infection remains high among them; and there has been a resurgence of HIV infection among MSM, parti...

    Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children

    Increasing access to antiretroviral therapy (ART) has transformed the prognosis of HIVinfected patients in resource-limited settings (RLS). However, treatment coverage remains relatively low, and HIV diagnosis occurs at a late stage. As a result, many patients continue to die of HIV-related opportunistic...

    Guidelines for the programmatic management of drug-resistant tuberculosis – 2011 update

    This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and extensi...

    Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement

    Commercial liquid culture systems and molecular line-probe assays have been endorsed by the World Health Organization (WHO) as gold standards for rapid detection of multidrug-resistant (MDR) tuberculosis (TB); however, because of technical complexity, cost and the requirement for sophisticated laboratory...

    Use of tuberculosis interferon-gamma release assays (‎IGRAs)‎ in low- and middle-income countries: policy statement

    Research over the past decade has resulted in the development of two commercial interferongamma release assays (IGRAs), based on the principle that the T-cells of individuals who have acquired TB infection respond to re-stimulation with Mycobacterium tuberculosis-specific antigens by secreting interferon...